Medications for Congenital Amegakaryocytic Thrombocytopenia

5 results
VistaPharm, LLC
Usage: Aminocaproic acid is indicated for enhancing hemostasis in bleeding due to fibrinolysis, particularly in life-threatening situations. It is used in cases involving surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, neoplastic diseases, and excessive urinary tract bleeding related to surgeries or conditions affecting the genitourinary system.
Seton Pharmaceuticals, LLC
Usage: Aminocaproic acid tablets enhance hemostasis in cases where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary bleeding following surgical or nonsurgical procedures in the genitourinary system.
Optimus Pharma Private Limited
Usage: Aminocaproic acid tablets enhance hemostasis in bleeding due to fibrinolysis, particularly in surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. They also address excessive urinary tract fibrinolytic bleeding post-surgery or due to genitourinary diseases. Emergency measures may be needed in severe cases.
Biocon Pharma Inc.
Usage: Aminocaproic acid is indicated for enhancing hemostasis in scenarios where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, hepatic cirrhosis, and related neoplastic diseases. It is also used for excessive urinary tract bleeding following surgical or nonsurgical interventions.
airis PHARMA Private Limited
Usage: Aminocaproic acid oral solution is indicated for enhancing hemostasis in cases of fibrinolytic bleeding, particularly post-heart surgery, in hematological disorders, during acute abruptio placentae, in hepatic cirrhosis, and certain cancers. It can also address excessive urinary tract bleeding linked to surgical or nonsurgical hematuria.